From the model, it can be concluded also that for those patients with GM-CSF serum levels ≤250.7 pg·mL−1 and >10.7 pg·mL−1, metastasis development would be predicted within the first 21.5 months after excision of the primary melanoma. The gene discussed is CSF2; the disease is melanoma.